Chronic AF267B administration in the 3×Tg-AD model was shown to rescue cognitive deficits in a spatial task and reduce Aβ and tau pathologies in the hippocampus due to GSK-3β inhibition [83]. The gene discussed is MAPT; the disease is Alzheimer disease.